Trushin, Sergey
Nguyen, Thi Kim Oanh
Ostroot, Mark
Nesbitt, Jarred J.
Kovalenko, Tetiana
Galkin, Alexander
Nambara, Toshihiko
Lu, Wenyan
Kanekiyo, Takahisa
Johnson, Graham
Trushina, Eugenia https://orcid.org/0000-0002-6291-2860
Funding for this research was provided by:
Alzheimer's Association (23AARF-1027342)
NIH (U19 AG069701)
NIH (R01AG 55549)
Article History
Received: 14 April 2026
Accepted: 10 August 2026
First Online: 2 September 2026
Declarations
Competing interests: E.T. is the inventor on U.S. Patent No.12,017,992 “Compounds for modulating mitochondrial function” assigned to Mayo Foundation for Medical Education and Research and issued on June25, 2024. E.T., S.T., M.O. and T.K.O.N. are inventors on the patent “Mitochondrial Complex I inhibitors”, application number 63/746,026, filed by Mayo Foundation for Medical Education and Research on 03-02-2026. The other authors declare no competing financial or non-financial interests.